These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 3013202)

  • 1. Chronic exposure of human cells in culture to the tricyclic antidepressant desipramine reduces the number of beta-adrenoceptors.
    Honegger UE; Disler B; Wiesmann UN
    Biochem Pharmacol; 1986 Jun; 35(11):1899-902. PubMed ID: 3013202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reevaluation of the regulation of beta-adrenergic receptor binding by desipramine treatment.
    Riva MA; Creese I
    Mol Pharmacol; 1989 Jul; 36(1):211-8. PubMed ID: 2546051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desipramine administration in the olfactory bulbectomized rat: changes in brain beta-adrenoceptor and 5-HT2A binding sites and their relationship to behaviour.
    Mudunkotuwa NT; Horton RW
    Br J Pharmacol; 1996 Apr; 117(7):1481-6. PubMed ID: 8730743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the tricyclic antidepressant desipramine on beta-adrenergic receptors in cultured rat glioma C6 cells.
    Fishman PH; Finberg JP
    J Neurochem; 1987 Jul; 49(1):282-9. PubMed ID: 3035098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of rat beta-adrenoceptors by clenbuterol or desipramine does not require chronic treatment: [3H] CGP-12177 binding reveals rapid (24 hour) modulation.
    Newman-Tancredi A; Verrièle L; Chaput C; Millan MJ
    Brain Res Bull; 1996; 41(2):93-6. PubMed ID: 8879672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human fibroblast cultures as a tool for the study of antidepressant drug action.
    Honegger UE
    Schweiz Arch Neurol Psychiatr (1985); 1986; 137(5):59-65. PubMed ID: 2431473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The significance of beta-adrenoceptor down regulation in the desipramine action in the forced swimming test.
    Kitada Y; Miyauchi T; Kosasa T; Satoh S
    Naunyn Schmiedebergs Arch Pharmacol; 1986 May; 333(1):31-5. PubMed ID: 2874504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of beta 1- and beta 3-adrenoceptors in intact brown adipocytes of the rat.
    D'Allaire F; Atgié C; Mauriège P; Simard PM; Bukowiecki LJ
    Br J Pharmacol; 1995 Jan; 114(2):275-82. PubMed ID: 7881727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acidic sphingomyelinase: relationship with antidepressant-induced desensitization of beta-adrenoceptors.
    Carre JB; Boutry JM; Baumann N; Maurin Y
    Life Sci; 1988; 42(7):769-74. PubMed ID: 2828803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adrenergic and serotonergic receptor binding in rat brain after chronic desmethylimipramine treatment.
    Bergstrom DA; Kellar KJ
    J Pharmacol Exp Ther; 1979 May; 209(2):256-61. PubMed ID: 220405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between electrocortical activity and beta-adrenergic receptor function in the rat after chronic desimipramine treatment.
    Krijzer FN; Schipper J; Tulp MT; Koopman PA
    J Neural Transm Gen Sect; 1989; 78(1):73-87. PubMed ID: 2547025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of chronic antidepressant treatment on beta-adrenoceptor subtype binding in the rat cerebral cortex and cerebellum.
    Paetsch PR; Greenshaw AJ
    Mol Chem Neuropathol; 1993 Sep; 20(1):21-31. PubMed ID: 7902719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Desipramine-induced down regulation of beta-adrenergic receptors: effects of noradrenergic and serotonergic neuronal activities and of alpha 2-adrenergic receptor mediated mechanisms].
    Matsubara S
    Hokkaido Igaku Zasshi; 1987 Mar; 62(2):301-10. PubMed ID: 3038720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subcellular distribution of beta-adrenoceptors in brain following administration of antidepressant drugs.
    Koshikawa N; Durcan MJ; Weaver K; Lawrence K; Campbell IC
    Neuropharmacology; 1987 Sep; 26(9):1343-9. PubMed ID: 2823164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agonist interactions with beta-adrenergic receptors following chronic administration of desipramine or the atypical antidepressants, iprindole and mianserin.
    Hancock AA; Marsh CL
    J Recept Res; 1985; 5(5-6):311-34. PubMed ID: 2868124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid down-regulation of beta-adrenergic receptors evoked by combined forced swimming test and CGP 37849--a competitive antagonist of NMDA receptors.
    Wedzony K; Klimek V; Nowak G
    Pol J Pharmacol; 1995; 47(6):537-40. PubMed ID: 8868377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-Hydroxytryptamine2 and beta-adrenergic receptor regulation in rat brain following chronic treatment with desipramine and fluoxetine alone and in combination.
    Goodnough DB; Baker GB
    J Neurochem; 1994 Jun; 62(6):2262-8. PubMed ID: 8189233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postsynaptic alpha-2 adrenergic receptors are critical for the antidepressant-like effects of desipramine on behavior.
    Zhang HT; Whisler LR; Huang Y; Xiang Y; O'Donnell JM
    Neuropsychopharmacology; 2009 Mar; 34(4):1067-77. PubMed ID: 18923403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic desipramine treatment prevents the upregulation of cortical beta-receptors caused by a single dose of the benzodiazepine inverse agonist FG7142.
    Stanford SC; Taylor SC; Little HJ
    Eur J Pharmacol; 1987 Jul; 139(2):225-32. PubMed ID: 2820760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of rat cerebral cortical opiate receptors following chronic desimipramine treatment.
    Reisine T; Soubrie P
    Eur J Pharmacol; 1982 Jan; 77(1):39-44. PubMed ID: 6277652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.